ArcBest (ARCB) Reaches $32.75 After 8.00% Down Move; Moore Medical (MMD) Has 1.17 Sentiment

February 15, 2018 - By Darrin Black

The stock decreased 0.16% or $0.031 during the last trading session, reaching $19.039. About 22,915 shares traded. MainStay DefinedTerm Municipal Opportunities Fund (MMD) has declined 0.25% since February 15, 2017 and is downtrending. It has underperformed by 16.95% the S&P500.

The stock of ArcBest Corporation (NASDAQ:ARCB) is a huge mover today! The stock decreased 2.38% or $0.8 during the last trading session, reaching $32.75. About 71,215 shares traded. ArcBest Corporation (NASDAQ:ARCB) has risen 10.70% since February 15, 2017 and is uptrending. It has underperformed by 6.00% the S&P500.The move comes after 6 months negative chart setup for the $839.84M company. It was reported on Feb, 15 by Barchart.com. We have $30.13 PT which if reached, will make NASDAQ:ARCB worth $67.19M less.

Among 10 analysts covering Arcbest Corporation (NASDAQ:ARCB), 0 have Buy rating, 1 Sell and 9 Hold. Therefore 0 are positive. Arcbest Corporation has $45 highest and $17 lowest target. $32.56’s average target is -0.58% below currents $32.75 stock price. Arcbest Corporation had 40 analyst reports since August 5, 2015 according to SRatingsIntel. Cowen & Co maintained ArcBest Corporation (NASDAQ:ARCB) rating on Monday, July 10. Cowen & Co has “Buy” rating and $2700 target. The rating was downgraded by Cowen & Co to “Market Perform” on Monday, October 16. The company was maintained on Monday, November 20 by KeyBanc Capital Markets. The rating was maintained by Citigroup with “Neutral” on Thursday, February 4. The firm earned “Equal-Weight” rating on Thursday, January 7 by Stephens. The company was upgraded on Friday, November 4 by Bank of America. Citigroup maintained ArcBest Corporation (NASDAQ:ARCB) rating on Tuesday, February 6. Citigroup has “Neutral” rating and $40 target. Bank of America maintained ArcBest Corporation (NASDAQ:ARCB) rating on Monday, February 22. Bank of America has “Underperform” rating and $17 target. Stifel Nicolaus upgraded ArcBest Corporation (NASDAQ:ARCB) on Thursday, February 4 to “Buy” rating. Stifel Nicolaus maintained ArcBest Corporation (NASDAQ:ARCB) on Thursday, January 18 with “Sell” rating.

ArcBest Corporation provides freight transportation services and integrated logistics solutions worldwide. The company has market cap of $839.84 million. The company??s Asset-Based segment transports general commodities, such as food, textiles, apparel, furniture, appliances, chemicals, nonbulk petroleum products, rubber, plastics, metal and metal products, wood, glass, automotive parts, machinery, and miscellaneous manufactured products through less-than-truckload services. It has a 14.56 P/E ratio. This segment also offers motor carrier freight transportation services to clients in Mexico through arrangements with trucking companies.

Summit Financial Wealth Advisors Llc holds 0.19% of its portfolio in MainStay DefinedTerm Municipal Opportunities Fund for 26,550 shares. Usca Ria Llc owns 73,206 shares or 0.19% of their US portfolio. Moreover, Regal Investment Advisors Llc has 0.11% invested in the company for 23,447 shares. The Colorado-based Advisors Asset Management Inc. has invested 0.09% in the stock. Advisory Services Network Llc, a Georgia-based fund reported 28,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: